Risk adjusted net present value: What is the current valuation of Incyte’s Epacadostat?

Epacadostat is a small molecule commercialized by Incyte, with a leading Phase II program in Salivary Gland Cancer.

Source link
#Risk #adjusted #net #present #current #valuation #Incytes #Epacadostat